This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB06867/identifier/pdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB06867/identifier/pubchem-compound/
n10http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB06867/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB06867/identifier/drugbank/
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n6http://linked.opendata.cz/resource/drugbank/drug/DB06867/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB06867/identifier/chebi/

Statements

Subject Item
n2:DB06867
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB06867 n15:DB06867
dcterms:title
3,6,9,12,15,18-HEXAOXAICOSANE
adms:identifier
n6:81438 n7:DB06867 n8:39576 n11:99443338 n12:16P n14:90206
n3:IUPAC-Name
n4:271B5996-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B599C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B599B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5998-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5999-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B599A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5994-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5995-363D-11E5-9242-09173F13E4C5 n4:271B5992-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5993-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B59A2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B59A3-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B599D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B599E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B59A0-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B599F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B59A1-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B59A7-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B59A9-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B59AA-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B59A6-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B59A5-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B59A8-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5997-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B59A4-363D-11E5-9242-09173F13E4C5